DYN

Insider trade Purchase by Posner Brian S

4d ago

Insider trade Purchase by Posner Brian S

10d ago

News Dyne spikes as late-stage trial for Duchenne therapy gets underway

13d ago

News Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React

14d ago

News Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

14d ago

Insider trade Sale by Johanna Friedl-Naderer (Chief Commercial Officer)

18d ago

Insider trade Sale by Douglas Kerr (Chief Medical Officer)

18d ago

Insider trade Sale by Erick Lucera (Chief Financial Officer)

18d ago

Insider trade Sale by John Cox (CEO & President)

18d ago

News Dyne Therapeutics GAAP EPS of -$0.73 beats by $0.04

22d ago

SEC filing DYN Reports $62.4M Q1 Revenue, $134.6M Cash, Advances z-rostudirsen to BLA Filing in Q2 2026, Initiates Phase 3 HARMONIA Trial for z-basivarsen

22d ago

Insider trade Sale by Jason P Rhodes

26d ago

Insider trade Sale by Jason P Rhodes

32d ago

Insider trade Sale by Jason P Rhodes

35d ago

Insider trade Sale by Dirk Kersten

39d ago

Insider trade Sale by Dirk Kersten

39d ago

Insider trade Sale by Jason P Rhodes

39d ago

Insider trade Sale by Dirk Kersten

39d ago

Insider trade Sale by Dirk Kersten

39d ago

Insider trade Sale by Jason P Rhodes

40d ago

Insider trade Sale by Dirk Kersten

41d ago

Insider trade Sale by Dirk Kersten

45d ago

Insider trade Purchase by Brian S Posner

80d ago

Insider trade Sale by Dirk Kersten

80d ago

Scanner Unusual buy pressure (4.1x avg, 80% up-volume, +10.4% / +1.85 intraday, above VWAP)

84d ago